Background: The landscape of attitudes, legal status and patterns of use of cannabis is
rapidly changing in the United States and elsewhere. Therefore, the primary aim of this …

Cannabis and classic psychedelics are controlled substances with emerging evidence of
efficacy in the treatment of a variety of psychiatric illnesses. Cannabis has largely not been …

Rationale There has been increasing attention on cannabis use for medical purposes, but
there is currently a lack of data on its epidemiology. Objectives To examine the …

Rationale Cannabis-based medicinal products (CBMPs) have been identified as novel
therapeutics for generalised anxiety disorder (GAD) based on pre-clinical models; however …

Purpose During the treatment of cancer, 18% of patients use cannabis for symptom
management. Anxiety, depression, and sleep disturbances are common symptoms in …

Background The impact of the COVID-19 pandemic and consequent public health
restrictions on the mental health of adolescents is of global concern. The purpose of this …

Abstract Purpose of Review This review will address the many uncertainties surrounding the
medical use of cannabidiol (CBD). We will begin with an overview of the legal and …

Objective: People with ADHD are more likely to use cannabis but little is known about the
effects of cannabis on ADHD symptoms, ADHD medication side effects, or ADHD-related …

Introduction: Cannabigerol (CBG), and its precursor before decarboxylation, cannabigerolic
acid is sometimes labeled the “mother of all cannabinoids.” The purpose of the present study …

Stress and substance use disorders remain two of the most highly prevalent psychiatric
conditions and are often comorbid. While individually these conditions have a debilitating …